跳至主要内容
临床试验/CTRI/2025/04/085284
CTRI/2025/04/085284尚未招募3 期

Randomised Open Controlled Clinical Study To Evaluate The Efficacy Of Maghadadyam Churna In Tamak Shwas w s r to Bronchial Asthma

Dr Sashank Sukdatta Borkar1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年6月5日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
To Study the effect of Maghadadyam Churna with madhu internally in Tamak Shwasa by assesing Shwasa vega ghurghurakam FEV1

研究概览

简要总结

This is  Randomised open controlled clinical trial to evaluate the Efficacy of Maghadadyam Churna  in Tamak Shwasa w.s.r to Bronchial Asthma

The assesment of signs and symptoms will be done at regular follow ups

Observations will be drawn from the outcomes achieved in 30 days

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • All the subjects of all gender between 18 to 60 years of age All diagnosed with Tamak shwas as per Ayurveda Classical symptoms as shwas ghurghurakam vega
  • Patients having FEV1 greater than 80 percent of predicted.

排除标准

  • Having any major illness and known history of TB IHD CCF HTN DM HIV COVID Asbestosis Silicosis Severe asthamatic patients in avegavashtha.

结局指标

主要结局

To Study the effect of Maghadadyam Churna with madhu internally in Tamak Shwasa by assesing Shwasa vega ghurghurakam FEV1

时间窗: 30 days

次要结局

  • 1)To study Tamak shwasa in details from various Ayurvedic Texts(2)To study efficacy of Maghadadyam churna in signs of shwas,ghurghurakam,kasa in Tamak shwasa)

研究者

发起方
Dr Sashank Sukdatta Borkar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验